CING NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Cingulate Inc · Healthcare · Biotechnology

Latest close 4.79 USD
3.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -13.4% below the Trend Line and sits at 18.7% of its 52-week range. The latest completed week returned 3.2%, after a -11.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 36/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 16d.

Setup score 20 out of 100
Latest Close 4.79 USD 31 Jul 2026
1W Return 3.2% latest completed week
4W Return -11.0% short-term follow-through
12W Return -9.1% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.4% below the Trend Line and sits at 18.7% of its 52-week range. The latest completed week returned 3.2%, after a -11.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.23

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -11.0% over four weeks, -9.1% over 12 weeks, and -6.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.2%
4W-11.0%
12W-9.1%
26W-16.6%
52W-6.1%
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.54Latest activity-pressure read.
Pressure change32.2%Four-week change in activity pressure.
Leadership-10.00Latest relative-leadership reading.
RS change-119.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value58/100Relative valuation strength. Underlying universe rank 43; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum58/100Medium-term price momentum. Underlying universe rank 43; rank 1 is best.
Growth58/100Revenue and earnings growth. Underlying universe rank 43; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-43.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-4521.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-48.2%
Net share repurchases relative to market value.
Shareholder yield
-48.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

CING shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.40, expected move of 23.5%, and Sharemaestro trend signal inactive.

Conviction36/100
Expected move23.5%
Put/call volume0.40
Pressure47
Speculation0
Volatility96
Trend agreement26
Open options detail
Insider activity14 / 0

14 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 55 relevant articles.

9 positive · 41 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings16dNext report is scheduled for 18 Aug 2026; event risk rises as the date approaches.
Options expected move23.5%Nearest-chain priced movement where available.
52-week drawdown-59.7%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+35.1%Week of 13 Mar.
Worst week-22.1%Week of 13 Feb.
Latest week+3.2%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains5
Flat weeks0
Modest losses6
Sharp losses9
Recent vol6.7%13-week weekly-return volatility.
Base vol10.9%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew8.7% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20264.79 USD3.2%5.53 USD21.51 USD-0.54-10.00701.6KOff
24 Jul 20264.64 USD2.2%5.51 USD22.31 USD-0.59-12.83634.1KOff
17 Jul 20264.54 USD-7.5%5.50 USD23.10 USD-0.69-16.681.3MOff
10 Jul 20264.91 USD-8.7%5.48 USD24.21 USD-0.72-14.212.0MOff
3 Jul 20265.38 USD8.5%5.46 USD25.40 USD-0.80-4.561.5MOff
26 Jun 20264.96 USD-0.6%5.42 USD26.79 USD-0.83-11.291.2MOff
19 Jun 20264.99 USD2.3%5.38 USD28.19 USD-0.79-14.852.1MOff
12 Jun 20264.88 USD8.6%5.33 USD29.58 USD-0.83-14.741.4MOff
5 Jun 20264.50 USD8.1%5.28 USD30.84 USD-0.81-19.898.8MOff
29 May 20264.16 USD-6.9%5.26 USD32.35 USD-0.88-29.524.1MOff
22 May 20264.47 USD-2.2%5.24 USD33.99 USD-0.83-22.441.7MOff
15 May 20264.57 USD-13.3%5.22 USD35.33 USD-0.71-19.932.8MOff
8 May 20265.27 USD-1.9%5.20 USD36.81 USD-0.61-8.161.8MOn
1 May 20265.37 USD-1.8%5.16 USD38.35 USD-0.45-1.472.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.